Examining Community-based Effectiveness of a Substance Use and HIV Risk Reduction Intervention for Young Men of Color

Study Overview
=================
Brief Summary
-----------------
This study will conduct an effectiveness trial of the 4-session evidence-based YMHP intervention for YMSM of color ages 15-29 at two CBOs in New York City, compared to usual care.

Detailed Description
-----------------
We will conduct a comparative effectiveness trial (CET) with two intensities of treatment to be offered following field-based HIV counseling and testing (C&T) - the YMHP intervention and an enhanced treatment as usual (eTAU) condition involving HIV prevention services provided at two community based organizations (CBOs) to test their relative effectiveness in reducing substance use and sexual risk behavior among HIV-negative MYMSM. In collaboration with two CBOs, our goals are to better understand substance use and sexual health-related outcomes among HIV-negative MYMSM who are unlikely to be treatment seeking and to implement the YMHP intervention in a way that will maximize portability and scalability. Working together with our collaborators will help to address practical problems at the frontline of service provision to pave the way for a comprehensive program to reduce substance use and HIV infection among MYMSM.

Official Title
-----------------
Examining Community-based Effectiveness of a Substance Use and HIV Risk Reduction Intervention for Young Men of Color

Conditions
-----------------
Substance Use, Sexual Risk

Intervention / Treatment
-----------------
* Behavioral: YMHP Intervention
* Behavioral: Enhanced Treatment as Usual


Participation Criteria
=================
Eligibility Criteria
-----------------
Inclusion Criteria: HIV-negative test result from the past 90 days 15-29 years of age Born biologically male or currently identifying as male Sex with men in the past 90 days ≥ 5 days of illicit drug use in the past 90 days ≥ 1 episode of CAS in the past 90 days, or a positive STI test result in the past 90 days. Living in the New York City area Able to communicate in English Exclusion Criteria: Serious cognitive or psychiatric impairments ≥5 days of IDU drug use in the past 90 days Currently taking Truvada as Pre-Exposure Prophylaxis (PrEP)

Ages Eligible for Study
-----------------
Minimum Age: 15 Years
Maximum Age: 29 Years

Sexes Eligible for Study
-----------------
Male

Accepts Healthy Volunteers
-----------------
Accepts Healthy Volunteers

Study Plan
=================
How is the study designed?
-----------------

Design Details

Primary Purpose: Prevention
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Single


Arms and Interventions

| Participant Group/Arm | Intervention/Treatment |
| --- | --- |
| Other: Intervention<br> | Behavioral: YMHP Intervention<br> <br> |
| Other: Enhanced Treatment as Usual<br> | Behavioral: Enhanced Treatment as Usual<br> <br> * Other names: eTau;|

What is the study measuring?
-----------------
Primary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Days of Drug Use |  | Past 3 months | 
| Condomless Anal Sex Acts |  | Past 3 months | 
| STI |  | Past 3 months | 

Secondary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| PrEP Uptake |  | Past 3 months |